0.40
+0.088(+28.48%)
Currency In USD
Address
7800 Susquehanna St.
Pittsburgh, PA 15208
United States of America
Phone
412-894-1853
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
December 19, 2022
| Name | Title | Pay | Year Born |
| Dr. Jonathan Kaufman M.B.A., Ph.D. | Co-Founder, Chairman, Chief Executive Officer, President, Secretary & Treasurer | 233,300 | 1966 |
| Mr. Douglas Johnston CPA | Chief Financial Officer | 165,000 | 1985 |
| Dr. Michael B. Chancellor M.D. | Co-Founder, Chief Medical Officer & Director | 225,000 | 1958 |
| Ms. Janet Okonski | Director of Clinical Operations | 0 | N/A |
| Katie Johnston | Controller | 0 | N/A |
| Ms. Michele Gruber | Director of Operations | 0 | N/A |
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.